Related references
Note: Only part of the references are listed.Neuroimaging with PET/CT in chronic traumatic encephalopathy: what nuclear medicine can do to move the field forward
Luca Filippi et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2022)
Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning Analysis
Aurelija Jucaite et al.
MOVEMENT DISORDERS (2022)
Image Quantification for TSPO PET with a Novel Image-Derived Input Function Method
Yu-Hua Dean Fang et al.
DIAGNOSTICS (2022)
Recent developments on PET radiotracers for TSPO and their applications in neuroimaging
Lingling Zhang et al.
ACTA PHARMACEUTICA SINICA B (2021)
Hybrid Imaging of Vascular Cognitive Impairment
Viviana Frantellizzi et al.
SEMINARS IN NUCLEAR MEDICINE (2021)
Diagnostic Value of the Early Heart-to-Mediastinum Count Ratio in Cardiac 123I-mIBG Imaging for Parkinson's Disease
Viviana Frantellizzi et al.
CURRENT RADIOPHARMACEUTICALS (2021)
The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson's Disease
Christine Ghadery et al.
MOLECULAR NEUROBIOLOGY (2020)
Neuroimaging in Vascular Cognitive Impairment and Dementia: A Systematic Review
Viviana Frantellizzi et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Isolated head tremor: A DAT-SPECT and somatosensory temporal discrimination study
Gina Ferrazzano et al.
PARKINSONISM & RELATED DISORDERS (2020)
Translocator protein (TSPO): the new story of the old protein in neuroinflammation
Younghwan Lee et al.
BMB REPORTS (2020)
Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders
Eryn L. Werry et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
PET imaging of [11C]PBR28 in Parkinson's disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
Katarina Varnas et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
TSPO PET with [F-18]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis
Marcus Unterrainer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Microglial activation in Parkinson's disease using [18F]-FEPPA
Christine Ghadery et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Extrastriatal spreading of microglial activation in Parkinson's disease: a positron emission tomography study
Tatsuhiro Terada et al.
ANNALS OF NUCLEAR MEDICINE (2016)
Neuroinflammation: the devil is in the details
Damon J. DiSabato et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease
Aurelija Jucaite et al.
BRAIN (2015)
Imaging Striatal Microglial Activation in Patients with Parkinson's Disease
Yuko Koshimori et al.
PLOS ONE (2015)
Synthesis and Evaluation of Trans locator 18 kDa Protein (TSPO) Positron Emission Tomography (PET) Radioligands with Low Binding Sensitivity to Human Single Nucleotide Polymorphism rs6971
Paolo Zanotti-Fregonara et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Determination of [11C]PBR28 binding potential in vivo: a first human TSPO blocking study
David R. Owen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)
Microglia, Amyloid, and Glucose Metabolism in Parkinson's Disease with and without Dementia
Paul Edison et al.
NEUROPSYCHOPHARMACOLOGY (2013)
In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease
S. Iannaccone et al.
PARKINSONISM & RELATED DISORDERS (2013)
Diffusion-weighted imaging and its relationship to microglial activation in parkinsonian syndromes
Christopher Kobylecki et al.
PARKINSONISM & RELATED DISORDERS (2013)
11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration
G. D. Rabinovici et al.
NEUROLOGY (2007)
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
A Gerhard et al.
NEUROBIOLOGY OF DISEASE (2006)
Microglial activation and dopamine terminal loss in early Parkinson's disease
Y Ouchi et al.
ANNALS OF NEUROLOGY (2005)
Unchanged striatal dopamine transporter availability in narcolepsy: a PET study with [C-11]-CFT
JO Rinne et al.
ACTA NEUROLOGICA SCANDINAVICA (2004)